DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $716,513 | +9.2% | 2,888 | +5.6% | 0.01% | +25.0% |
| Q2 2023 | $656,160 | -13.2% | 2,734 | -8.8% | 0.00% | 0.0% |
| Q1 2023 | $755,616 | -0.5% | 2,998 | +4.8% | 0.00% | -20.0% |
| Q4 2022 | $759,101 | +12.8% | 2,860 | +9.8% | 0.01% | +25.0% |
| Q3 2022 | $673,000 | -0.4% | 2,604 | -2.3% | 0.00% | 0.0% |
| Q2 2022 | $676,000 | -18.1% | 2,665 | -5.3% | 0.00% | -33.3% |
| Q1 2022 | $825,000 | -10.9% | 2,813 | 0.0% | 0.01% | +20.0% |
| Q4 2021 | $926,000 | +8.8% | 2,813 | +0.6% | 0.01% | 0.0% |
| Q3 2021 | $851,000 | -4.4% | 2,796 | -15.7% | 0.01% | 0.0% |
| Q2 2021 | $890,000 | +17.4% | 3,316 | -1.5% | 0.01% | 0.0% |
| Q1 2021 | $758,000 | +4.4% | 3,366 | +3.1% | 0.01% | 0.0% |
| Q4 2020 | $726,000 | +2.4% | 3,266 | -0.8% | 0.01% | 0.0% |
| Q3 2020 | $709,000 | +19.6% | 3,291 | -1.8% | 0.01% | +25.0% |
| Q2 2020 | $593,000 | +27.3% | 3,351 | -0.4% | 0.00% | 0.0% |
| Q1 2020 | $466,000 | -10.9% | 3,364 | -1.3% | 0.00% | 0.0% |
| Q4 2019 | $523,000 | -61.6% | 3,409 | -63.8% | 0.00% | -60.0% |
| Q3 2019 | $1,361,000 | +0.5% | 9,426 | -0.5% | 0.01% | 0.0% |
| Q2 2019 | $1,354,000 | +12.4% | 9,476 | +3.8% | 0.01% | -9.1% |
| Q1 2019 | $1,205,000 | +28.1% | 9,130 | 0.0% | 0.01% | +10.0% |
| Q4 2018 | $941,000 | -5.1% | 9,130 | 0.0% | 0.01% | -23.1% |
| Q3 2018 | $992,000 | +8.3% | 9,130 | -1.6% | 0.01% | +30.0% |
| Q2 2018 | $916,000 | +0.8% | 9,280 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $909,000 | -1.6% | 9,280 | -6.8% | 0.01% | 0.0% |
| Q4 2017 | $924,000 | +14.2% | 9,955 | +5.6% | 0.01% | +11.1% |
| Q3 2017 | $809,000 | -6.3% | 9,430 | -7.8% | 0.01% | -10.0% |
| Q2 2017 | $863,000 | +0.7% | 10,230 | +2.1% | 0.01% | 0.0% |
| Q1 2017 | $857,000 | +8.5% | 10,020 | -1.2% | 0.01% | 0.0% |
| Q4 2016 | $790,000 | -6.9% | 10,140 | -6.4% | 0.01% | 0.0% |
| Q3 2016 | $849,000 | -22.5% | 10,838 | -0.1% | 0.01% | -28.6% |
| Q2 2016 | $1,096,000 | +6.4% | 10,854 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $1,030,000 | +10.2% | 10,854 | +7.8% | 0.01% | +7.7% |
| Q4 2015 | $935,000 | +8.5% | 10,070 | -0.5% | 0.01% | +8.3% |
| Q3 2015 | $862,000 | -1.3% | 10,122 | -0.8% | 0.01% | 0.0% |
| Q2 2015 | $873,000 | -0.2% | 10,200 | -1.0% | 0.01% | 0.0% |
| Q1 2015 | $875,000 | -1.2% | 10,305 | -0.3% | 0.01% | 0.0% |
| Q4 2014 | $886,000 | +12.3% | 10,338 | -0.4% | 0.01% | 0.0% |
| Q3 2014 | $789,000 | +1.4% | 10,380 | +5.1% | 0.01% | 0.0% |
| Q2 2014 | $778,000 | +11.0% | 9,880 | +5.7% | 0.01% | +9.1% |
| Q1 2014 | $701,000 | -2.4% | 9,351 | +0.5% | 0.01% | -8.3% |
| Q4 2013 | $718,000 | +9.8% | 9,308 | -1.3% | 0.01% | 0.0% |
| Q3 2013 | $654,000 | +3.6% | 9,430 | -5.4% | 0.01% | 0.0% |
| Q2 2013 | $631,000 | – | 9,970 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |